• Home
  • R&D
Redefining Healthy Longevity
Through Precision Immune Resilience

Regenerative Medicine

Shaping the Future of Therapeutics Through Regenerative Medicine

Our regenerative medicine program not only expands treatment opportunities for patients but also serves as a clinical translation engine for PRIME-NK, IMMUNOKINE, and AUTO-Treg. By accelerating clinical validation and real-world implementation, it bridges scientific innovation with meaningful patient impact.

  1. 01
    Regenerative Medicine Application

    Personalized cell therapy for patients

  2. 02
    Real-World Data (RWD) Generation

    Repeat-Dose Safety

    Treatment Response Patterns

    Manufacturing Consistency

  3. 03
    Clinical Trial Design Optimization

    Dose Optimization

    Treatment Scheduling

    Patient Population Definition

  4. 04
    Improved Probability
    of Clinical Success

    Reduced Development Risk

    Enhanced Likelihood of Succes

  5. 05
    Enhanced Strategic
    and Commercial Value

    Strengthened Global Partnerships

    Expanded Licensing and Market Opportunities

Creating a Virtuous Cycle of Innovation
Through Regenerative Medicine

A Catalyst for Sustainable Growth and Innovation

Regenerative Medicine

Regenerative Medicine Transforms Clinical Experience
into Therapeutic Innovation.

Patient Value

Advancing patient well-being and quality of life through innovative cell therapies

Data Value

Enhancing clinical decision-making through insights generated from RWD

Development Value

Increasing the probability of clinical success while reducing development time and cost

Market Value

Addressing unmet medical needs while creating new market opportunities

Beyond Today's Treatment, Regenerative Medicine
Drives Tomorrow's Innovation